FDA Vaccinia-Complication Draft Guidance Emphasizes Data Collection Systems
This article was originally published in The Pink Sheet Daily
Executive Summary
The second of three guidances on FDA's counter-terrorism plans strongly encourages early communication with the agency. Guidance on smallpox drug development is forthcoming.